OSE IMMUNOTHERAPEUTICS: ifrs:DilutedEarningsLossPerShare
| Value | {"amount": -1.06} |
|---|---|
| Period | 2020-01-01 – 2020-12-31 |
| Status | current |
| Entity | OSE IMMUNOTHERAPEUTICS |
Provenance
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference:
Retrieved: 2026-08-24T01:34:31.525092+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/b74a8299-9759-4a6c-adec-a996354579e6
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference:
esef:969500HIUWVGY6NZSM05:2021-12-31Retrieved: 2026-08-24T01:34:31.525092+02:00
Raw response sha256:
553cdcec3395c4f893e1c4627f901377…Cite as: FACTANKER, https://factanker.com/fact/b74a8299-9759-4a6c-adec-a996354579e6
History
- no predecessors — first report